UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism

Frontiers in immunology, 2018-07, Vol.9, p.1605-1605

2018

Volltextzugriff (PDF)

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Cancer discovery, 2020-08, Vol.10 (8), p.1194-1209

2020

Volltextzugriff (PDF)

Interplay between Immune Checkpoint Proteins and Cellular Metabolism

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (6), p.1245-1249

2017

Volltextzugriff (PDF)

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation

Cell & bioscience, 2016-04, Vol.6 (24), p.25-25, Article 25

2016

Volltextzugriff (PDF)

Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines

BMC medicine, 2013-08, Vol.11 (1), p.178-178, Article 178

2013

Volltextzugriff (PDF)

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Therapeutic advances in medical oncology, 2022-02, Vol.14, p.17588359221079125-17588359221079125

2022

Volltextzugriff (PDF)

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors

Cancer cell international, 2023-08, Vol.23 (1), p.1-172, Article 172

2023

Volltextzugriff (PDF)

Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1661-1678

2011

Volltextzugriff (PDF)

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib

JTO clinical and research reports, 2021-06, Vol.2 (6), p.100180-100180, Article 100180

2021

Volltextzugriff (PDF)

Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.4214-4224

2012

Volltextzugriff (PDF)

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Clinical & translational immunology, 2022, Vol.11 (1), p.e1364-n/a

2022

Volltextzugriff (PDF)

Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2231-2242

2016

Volltextzugriff (PDF)

Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768I

Molecular cancer therapeutics, 2020-11, Vol.19 (11), p.2298-2307

2020

Volltextzugriff (PDF)

Abstract 1106: BRAF and EGFR fusion as a novel mechanism of resistance mechanism to Lazertinib, 3rd- generation EGFR-TKI, in EGFR-mutant NSCLC

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1106-1106

2021

Volltextzugriff (PDF)

Antioxidant Enzymes Induced by Repeated Intake of Excess Energy in the Form of High-Fat, High-Carbohydrate Meals Are Not Sufficient to Block Oxidative Stress in Healthy Lean Individuals

Free radical biology & medicine, 2012-11, Vol.53, p.S84-S84

2012

Volltextzugriff (PDF)

Abstract 48: The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1α

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.48-48

2016

Volltextzugriff (PDF)

Abstract 48: The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.48-48

2016

Volltextzugriff (PDF)

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

European journal of cancer (1990), 2021-08, Vol.153, p.179-189

2021

Volltextzugriff (PDF)

Abstract 1996: Regulation of RNA splicing of the ErbB family receptors by the splicing cofactor SON

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1996-1996

2016

Volltextzugriff (PDF)

Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation

Oncotarget, 2016-05, Vol.7 (18), p.25113-25124

2016

Volltextzugriff (PDF)

Impact of Repeated Over-nutrition Intake: Randomized Controlled Trial

Free radical biology & medicine, 2010, Vol.49, p.S222-S222

2010

Volltextzugriff (PDF)

Mitochondria-targeted Antioxidants Protect Pancreatic β-cells against Oxidative Stress and Improve Insulin Secretion in Glucotoxicity and Glucolipotoxicity

Cellular physiology and biochemistry, 2011-01, Vol.28 (5), p.873-886

2011

Volltextzugriff (PDF)

Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells

Antioxidants & redox signaling, 2012-02, Vol.16 (3), p.245

2012

Volltextzugriff (PDF)

Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment

Antioxidants & redox signaling, 2017-01, Vol.26 (2), p.70

2017

Volltextzugriff (PDF)

Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections

Journal of medicinal chemistry, 2015-12, Vol.58 (24), p.9546-9561

2015

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(29)
Animals
(12)
Humans
(12)
Oncology
(10)
Mice
(9)
Reactive Oxygen Species - Metabolism
(7)
Female
(6)
Tumors
(6)
Apoptosis
(5)
Biological And Medical Sciences
(5)
Cell Line, Tumor
(5)
Biochemistry & Molecular Biology
(4)
Cancer
(4)
Cell Line
(4)
Lung Cancer
(4)
Patients
(4)
Phosphorylation
(4)
Reactive Oxygen Species
(4)
Signal Transduction
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Diverse Roles of Mitochondria in Immune Responses: Novel Insights Into Immuno-Metabolism

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Interplay between Immune Checkpoint Proteins and Cellular Metabolism

Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation

Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors

Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans

Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib

Carbonyl Reductase 1 Offers a Novel Therapeutic Target to Enhance Leukemia Treatment by Arsenic Trioxide

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α

Osimertinib, an Irreversible Next-Generation EGFR Tyrosine Kinase Inhibitor, Exerts Antitumor Activity in Various Preclinical NSCLC Models Harboring the Uncommon EGFR Mutations G719X or L861Q or S768I

Abstract 1106: BRAF and EGFR fusion as a novel mechanism of resistance mechanism to Lazertinib, 3rd- generation EGFR-TKI, in EGFR-mutant NSCLC

Antioxidant Enzymes Induced by Repeated Intake of Excess Energy in the Form of High-Fat, High-Carbohydrate Meals Are Not Sufficient to Block Oxidative Stress in Healthy Lean Individuals

Abstract 48: The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1α

Abstract 48: The immunoregulatory protein B7-H3 regulates reprogramming of cancer cell glucose metabolism through reactive oxygen species mediated stabilization of HIF-1

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

Abstract 1996: Regulation of RNA splicing of the ErbB family receptors by the splicing cofactor SON

Src drives the Warburg effect and therapy resistance by inactivating pyruvate dehydrogenase through tyrosine-289 phosphorylation

Impact of Repeated Over-nutrition Intake: Randomized Controlled Trial

Mitochondria-targeted Antioxidants Protect Pancreatic β-cells against Oxidative Stress and Improve Insulin Secretion in Glucotoxicity and Glucolipotoxicity

Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells

Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment

Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections

Suchergebnisse filtern